CIK 0001757499 · <br>Emerging growth company
Shuttle Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- SHPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (240) 403-4212
- Business address
- 401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD, 20879
- Former names
- Shuttle Pharmaceuticals Holdings, Inc.
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Open-market sale Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale Former Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale CEO and Chairman sold 8,372 shares at $1.61 ($13,437)
- 4 Open-market sale Chief Medical Officer sold 1,414 shares at $1.61 ($2,269)
- 4 Open-market sale Chief Scientific Officer sold 328 shares at $1.61 ($526)
- 4 Open-market sale Director sold 4,366 shares at $1.61 ($7,007)
- 4 Open-market sale President and COO sold 3,820 shares at $1.61 ($6,131)
- 4 Open-market sale Chief Financial Officer sold 2,243 shares at $1.61 ($3,600)
- 8-K Event Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change
Page 13 of 16 · 308 filings